287 results
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
Biosciences where he was responsible for defining the portfolio strategy and advancement of development plans toward regulatory approvals. He began his
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
positions of increasing responsibility. In her role as the Head of R&D strategy, she was responsible for characterizing the productivity of the portfolio … was responsible for R&D, Commercial and Manufacturing plans. Dr. Lindborg holds a Ph.D. in statistics from Baylor University.
Other than
8-K
EX-99.1
j65oo24c8
14 Aug 23
BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
7:21am
8-K
EX-10.1
3hvzkr scbu
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm
8-K
EX-4.1
3x3jxc3hle
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm